Table 3.
Number of separated explants after treatment with medium, LPS (10 µg/mL), MT (10–1000 µg/mL) combined with LPS (10 µg/mL) and silymarin (100 and 250 µg/mL) combined with LPS (10 µg/mL) for 24 h. Contaminated explants (three out of 66 explants in total) were excluded from results.
| Treatment | Number of explants | |
|---|---|---|
| LPS (µg/mL) | MT, silymarin (µg/mL) | Separated/total |
| 0 | 0 | 0/8 a |
| 10 | 0 | 9/9 b |
| 10 | MT 10 | 4/6 b |
| 10 | MT 100 | 3/9 b |
| 10 | MT 500 | 0/9 a |
| 10 | MT 1000 | 2/9 a |
| 10 | Silymarin 100 | 0/3 a |
| 10 | Silymarin 250 | 0/5 a |
a,b Superscripts indicate significant difference p < 0.05.